Amphotericin B transfer to CSF following intravenous administration of liposomal amphotericin B

Volker Strenger1, Andreas Meinitzer2, Josef Donnerer3

  • 1Department of Paediatrics and Adolescent Medicine, Medical University of Graz, Graz, Austria volker.strenger@medunigraz.at.

Abstract

Insights

Liposomal amphotericin B (LAmB) administered intravenously results in low but sustained cerebrospinal fluid (CSF) levels of amphotericin B (AmB) in pediatric patients. These levels remain steady for over 48 hours, potentially allowing for effective treatment of CNS fungal infections.

Area of Science:

  • Pharmacokinetics
  • Neuroscience
  • Infectious Diseases

Background:

  • Amphotericin B (AmB) and its lipid formulations are crucial for treating central nervous system (CNS) fungal infections.
  • The cerebrospinal fluid (CSF) pharmacokinetics of liposomal amphotericin B (LAmB) after intravenous administration are not well understood.

Purpose of the Study:

  • To characterize the CSF kinetics of AmB following intravenous LAmB administration in pediatric patients.
  • To determine AmB concentrations in CSF and serum and calculate transfer rates.

Main Methods:

  • CSF and serum samples were collected from 14 pediatric patients receiving prophylactic intravenous LAmB (3 mg/kg/day).
  • Samples were analyzed for AmB using High-Performance Liquid Chromatography (HPLC).
  • 30 CSF samples were obtained at various time points post-infusion.

Main Results:

  • CSF AmB levels ranged from 10-120 ng/mL, with one outlier at 529 ng/mL, 1-100 hours post-infusion.
  • Serum levels were approximately 1000-fold higher than CSF levels.
  • CSF levels exhibited a steady-state for over 48 hours, with a transfer rate of 0.02%-0.92% from serum.

Conclusions:

  • Intravenous LAmB yields low but sustained AmB concentrations in CSF.
  • The steady-state CSF levels persist beyond 48 hours.
  • Higher brain tissue concentrations may be achievable, suggesting potential efficacy for CNS fungal infections.

Related Concept Videos

Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to...
119
Drug Delivery: Parenteral Route01:29

Drug Delivery: Parenteral Route

The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
2.8K
Cerebrospinal Fluid01:21

Cerebrospinal Fluid

Cerebrospinal fluid (CSF) is a colorless liquid that flows around the brain and the spinal cord, playing a vital role in the protection, support, and overall function of the central nervous system (CNS). CSF production, circulation, and absorption are tightly regulated processes essential for the brain and spinal cord to function properly.
CSF Production
CSF is produced mainly in the choroid plexus, a network of capillaries and ependymal cells located within the ventricular system of the brain....
7.9K
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this...
14
Cerebral Edema l: Introduction01:19

Cerebral Edema l: Introduction

Cerebral edema is a pathological increase in brain water content that disrupts intracranial pressure regulation and impairs neurological function. Because the cranial vault is rigid, even modest increases in tissue volume can compromise cerebral perfusion, distort neural structures, and initiate secondary injury. Cerebral edema develops through four principal mechanisms: vasogenic, cytotoxic, interstitial, and ionic.Vasogenic EdemaVasogenic edema arises from disruption of the blood–brain...
20